Upnorth Investment Ltd 3
3 · TCR2 THERAPEUTICS INC. · Filed Feb 13, 2019
Insider Transaction Report
Form 3
Upnorth Investment Ltd
10% Owner
Holdings
- (indirect: By Upnorth Investment Limited)
Series A Preferred Stock
→ Common Stock (322,902 underlying) - (indirect: By Upnorth Investment Limited)
Series B Preferred Stock
→ Common Stock (1,614,517 underlying)
Footnotes (3)
- [F1]Each share of Series A Preferred Stock is convertible into shares of the Issuer's common stock, par value $0.0001 ("Common Stock") on a 6.1938:1 basis. Upon the closing of the Issuer's initial public offering, all shares of Series A Preferred Stock will convert into shares of Common Stock of the Issuer. The Series A Preferred Stock has no expiration date.
- [F2]The reported securities are owned directly by UpNorth Investment Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein.
- [F3]Each share of Series B Preferred Stock is convertible into shares of the Issuer's Common Stock on a 6.1938:1 basis. Upon the closing of the Issuer's initial public offering, all shares of Series B Preferred Stock will convert into shares of Common Stock of the Issuer. The Series B Preferred Stock has no expiration date.